Tuesday, July 21, 2026

pharma · Fibromyalgia · Primary Fibromyalgia · TNXP

Tonix Pharmaceuticals Holding

Tonix Pharmaceuticals Holding patent portfolio — 16 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

200 Connell Dr, Berkeley Heights, New Jersey 07922, US HQ
2007 Founded
154 Employees
Public company Type
TNXP · NYSE Ticker
Company details
Status
Public
HQ
200 Connell Dr, Berkeley Heights, New Jersey 07922, US
Founded
2007
Employees
154
Programs
4
Drugs
4
Patents
16
Intelligence · Patents

Tonix Pharmaceuticals Holding patents

16 pharmaceutical patents indexed for Tonix Pharmaceuticals Holding. 0 expire within 24 months.

Tonix Pharmaceuticals Holding has 16 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. US 12156897

    Magnesium-containing oxytocin formulations and methods of use

    Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 12097183

    Pharmaceutical composition for treating migraine

    Expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 12090139

    Formulations comprising triptan compounds

    Expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 11970554

    Labeled oxytocin and method of manufacture and use

    Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 11839594

    Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

    Expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 11737991

    Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

    Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 11389473

    Magnesium-containing oxytocin formulations and methods of use

    Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 11026898

    Eutectic formulations of cyclobenzaprine hydrochloride

    Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 10864175

    Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

    Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 10864176

    Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

    Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 10736859

    Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

    Expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 10357465

    Eutectic formulations of cyclobenzaprine hydrochloride

    Expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 10322094

    Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

    Expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 10117936

    Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

    Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 9956188

    Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

    Expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 9636408

    Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

    Expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Tonix Pharmaceuticals Holding have?

16 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Tonix Pharmaceuticals Holding patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.